Literature DB >> 29068583

The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.

Agnieszka Bożek1, Adam Reich1.   

Abstract

BACKGROUND: A wide variety of psoriasis assessment tools have been proposed to evaluate the severity of psoriasis in clinical trials and daily practice. The most frequently used clinical instrument is the psoriasis area and severity index (PASI); however, none of the currently published severity scores used for psoriasis meets all the validation criteria required for an ideal score.
OBJECTIVES: The aim of this study was to compare and assess the reliability of 3 commonly used assessment instruments for psoriasis severity: the psoriasis area and severity index (PASI), body surface area (BSA) and physician global assessment (PGA).
MATERIAL AND METHODS: On the scoring day, 10 trained dermatologists evaluated 9 adult patients with plaque-type psoriasis using the PASI, BSA and PGA. All the subjects were assessed twice by each physician. Correlations between the assessments were analyzed using the Pearson correlation coefficient. Intra-class correlation coefficient (ICC) was calculated to analyze intra-rater reliability, and the coefficient of variation (CV) was used to assess inter-rater variability.
RESULTS: Significant correlations were observed among the 3 scales in both assessments. In all 3 scales the ICCs were > 0.75, indicating high intra-rater reliability. The highest ICC was for the BSA (0.96) and the lowest one for the PGA (0.87). The CV for the PGA and PASI were 29.3 and 36.9, respectively, indicating moderate inter-rater variability. The CV for the BSA was 57.1, indicating high inter-rater variability.
CONCLUSIONS: Comparing the PASI, PGA and BSA, it was shown that the PGA had the highest inter-rater reliability, whereas the BSA had the highest intra-rater reliability. The PASI showed intermediate values in terms of interand intra-rater reliability. None of the 3 assessment instruments showed a significant advantage over the other. A reliable assessment of psoriasis severity requires the use of several independent evaluations simultaneously.

Entities:  

Keywords:  BSA; PASI; PGA; measurement tools; psoriasis

Mesh:

Year:  2017        PMID: 29068583     DOI: 10.17219/acem/69804

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  29 in total

1.  Squamous Cell Carcinoma Antigen in Psoriasis: An Immunohistochemical Study.

Authors:  Soheir Ghonemy; Basma Mohamed; Kamal Elkashishy; Al-Shimaa M Ibrahim
Journal:  J Clin Aesthet Dermatol       Date:  2021-09

2.  Adrenocorticotropin/cortisol ratio - a marker of psoriasis severity.

Authors:  Radosław Pietrzak; Paweł Rykowski; Anna Pasierb; Zbigniew Bartoszewicz; Małgorzata Stakun; Małgorzata Rykowska; Katarzyna Karoń; Lidia Rudnicka; Joanna Czuwara
Journal:  Postepy Dermatol Alergol       Date:  2019-04-09       Impact factor: 1.837

3.  A description of treatment patterns of psoriasis by medical providers and disease severity in US women.

Authors:  Mahroo Tajalli; Tricia Li; Aaron M Drucker; Abrar A Qureshi; Eunyoung Cho
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2020-11-03

Review 4.  Measuring Outcomes in Psoriatic Arthritis.

Authors:  Alexis Ogdie; Laura C Coates; Philip Mease
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

5.  All‑trans retinoic acid alters the expression of the tight junction proteins Claudin‑1 and ‑4 and epidermal barrier function‑associated genes in the epidermis.

Authors:  Jing Li; Qianying Li; Songmei Geng
Journal:  Int J Mol Med       Date:  2019-02-15       Impact factor: 4.101

6.  Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark.

Authors:  Christoffer Blegvad; Anne-Marie Nybo Andersen; Jonathan Groot; Claus Zachariae; Lone Skov
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

7.  Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study.

Authors:  Eva Klingberg; Annelie Bilberg; Sofia Björkman; Martin Hedberg; Lennart Jacobsson; Helena Forsblad-d'Elia; Hans Carlsten; Björn Eliasson; Ingrid Larsson
Journal:  Arthritis Res Ther       Date:  2019-01-11       Impact factor: 5.156

8.  The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial.

Authors:  Alireza Yargholi; Leila Shirbeigi; Roja Rahimi; Parvin Mansouri; Mohammad Hossein Ayati
Journal:  BMC Res Notes       Date:  2021-06-30

9.  Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity.

Authors:  Maria Esposito; Alessandro Giunta; Roberta Croce Nanni; Silvia Criscuolo; Valeria Manfreda; Ester Del Duca; Luca Bianchi; Alfonso Troisi
Journal:  Arch Dermatol Res       Date:  2020-08-10       Impact factor: 3.017

10.  Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin.

Authors:  Mantas Žurauskas; Ronit Barkalifa; Aneesh Alex; Marina Marjanovic; Darold R Spillman; Prabuddha Mukherjee; Craig D Neitzel; Warren Lee; Jeremy Medler; Zane Arp; Matthew Cleveland; Steve Hood; Stephen A Boppart
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.